358 related articles for article (PubMed ID: 29416121)
1. In vitro activity of minocycline combined with aminoglycosides against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
Wentao N; Guobao L; Jin Z; Junchang C; Rui W; Zhancheng G; Youning L
J Antibiot (Tokyo); 2018 May; 71(5):506-513. PubMed ID: 29416121
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
[TBL] [Abstract][Full Text] [Related]
3. Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacin.
Tang HJ; Lai CC; Chen CC; Zhang CC; Weng TC; Chiu YH; Toh HS; Chiang SR; Yu WL; Ko WC; Chuang YC
J Microbiol Immunol Infect; 2019 Apr; 52(2):273-281. PubMed ID: 27133391
[TBL] [Abstract][Full Text] [Related]
4.
Huang D; Yu B; Diep JK; Sharma R; Dudley M; Monteiro J; Kaye KS; Pogue JM; Abboud CS; Rao GG
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438930
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
[TBL] [Abstract][Full Text] [Related]
6. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.
Gaibani P; Lombardo D; Lewis RE; Mercuri M; Bonora S; Landini MP; Ambretti S
J Antimicrob Chemother; 2014 Jul; 69(7):1856-65. PubMed ID: 24648503
[TBL] [Abstract][Full Text] [Related]
8. Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance.
Galani I; Nafplioti K; Adamou P; Karaiskos I; Giamarellou H; Souli M;
BMC Infect Dis; 2019 Feb; 19(1):167. PubMed ID: 30770727
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of ceftazidime/avibactam alone and in combination with amikacin, colistin and tigecycline against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae by in vitro time-kill experiment.
Wang F; Zhou Q; Yang X; Bai Y; Cui J
PLoS One; 2021; 16(10):e0258426. PubMed ID: 34648556
[TBL] [Abstract][Full Text] [Related]
10. Study of
Zhang W; Guo Y; Yang Y; Dong D; Zheng Y; Zhu D; Hu F
Microb Drug Resist; 2020 Mar; 26(3):204-210. PubMed ID: 31553260
[No Abstract] [Full Text] [Related]
11. Time-kill synergy tests of tigecycline combined with imipenem, amikacin, and ciprofloxacin against clinical isolates of multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
Yim H; Woo H; Song W; Park MJ; Kim HS; Lee KM; Hur J; Park MS
Ann Clin Lab Sci; 2011; 41(1):39-43. PubMed ID: 21325253
[TBL] [Abstract][Full Text] [Related]
12. Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing
Huang Y; Sokolowski K; Rana A; Singh N; Wang J; Chen K; Lang Y; Zhou J; Kadiyala N; Krapp F; Ozer EA; Hauser AR; Li J; Bulitta JB; Bulman ZP
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0069221. PubMed ID: 34152820
[TBL] [Abstract][Full Text] [Related]
13. Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents.
Almaghrabi R; Clancy CJ; Doi Y; Hao B; Chen L; Shields RK; Press EG; Iovine NM; Townsend BM; Wagener MM; Kreiswirth B; Nguyen MH
Antimicrob Agents Chemother; 2014 Aug; 58(8):4443-51. PubMed ID: 24867988
[TBL] [Abstract][Full Text] [Related]
14. Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae.
Tascini C; Tagliaferri E; Giani T; Leonildi A; Flammini S; Casini B; Lewis R; Ferranti S; Rossolini GM; Menichetti F
Antimicrob Agents Chemother; 2013 Aug; 57(8):3990-3. PubMed ID: 23752510
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.
Tängdén T; Hickman RA; Forsberg P; Lagerbäck P; Giske CG; Cars O
Antimicrob Agents Chemother; 2014; 58(3):1757-62. PubMed ID: 24395223
[TBL] [Abstract][Full Text] [Related]
16. fosA3 overexpression with transporter mutations mediates high-level of fosfomycin resistance and silence of fosA3 in fosfomycin-susceptible Klebsiella pneumoniae producing carbapenemase clinical isolates.
Singkham-In U; Muhummudaree N; Chatsuwan T
PLoS One; 2020; 15(8):e0237474. PubMed ID: 32857767
[TBL] [Abstract][Full Text] [Related]
17. Effect of Porins and bla
Balabanian G; Rose M; Manning N; Landman D; Quale J
Microb Drug Resist; 2018 Sep; 24(7):877-881. PubMed ID: 29782237
[TBL] [Abstract][Full Text] [Related]
18. Repurposing the anti-viral drug zidovudine (AZT) in combination with meropenem as an effective treatment for infections with multi-drug resistant, carbapenemase-producing strains of Klebsiella pneumoniae.
DeSarno AE; Parcell BJ; Coote PJ
Pathog Dis; 2020 Dec; 78(9):. PubMed ID: 33053176
[TBL] [Abstract][Full Text] [Related]
19. Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae.
He F; Fu Y; Chen Q; Ruan Z; Hua X; Zhou H; Yu Y
PLoS One; 2015; 10(3):e0119064. PubMed ID: 25734903
[TBL] [Abstract][Full Text] [Related]
20. Synergy of polymyxin B and minocycline against KPC-3- and OXA-48-producing Klebsiella pneumoniae in dynamic time-kill experiments: agreement with in silico predictions.
Olsson A; Malmberg C; Zhao C; Friberg LE; Nielsen EI; Lagerbäck P; Tängdén T
J Antimicrob Chemother; 2024 Feb; 79(2):391-402. PubMed ID: 38158772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]